Springer Healthcare Italia

Editore
Fascicolo, Current therapeutics : XXIX, 1, 2026, Springer Healthcare

Current therapeutics : XXIX, 1, 2026
[Trattamento enzimatico sostitutivo con velmanase alfa in pazienti affetti da alfa-mannosidosi : volume 2]

2026 - Springer Healthcare Italia

Fa parte di

Current therapeutics. - Mensile = Monthly
Leggi le condizioni d'uso
Disponibile DownloadDisponibile Copia/IncollaDisponibile Stampa
PDF

Fascicolo
Fascicolo, Current therapeutics : XXIX, 3, 2026, Springer Healthcare

Current therapeutics : XXIX, 3, 2026
[Complications and Management of Hyaluronic Acid Fillers : a Narrative Review with Case Reports]

2026 - Springer Healthcare Italia

Fa parte di

Current therapeutics. - Mensile = Monthly
Leggi le condizioni d'uso
Disponibile DownloadDisponibile Copia/IncollaDisponibile Stampa
PDF

Fascicolo
Fascicolo, Current therapeutics : XXVIII, 5, 2025, Springer Healthcare

Current therapeutics : XXVIII, 5, 2025
[Trattamento enzimatico sostitutivo con velmanase alfa in pazienti affetti da alfa-mannosidosi]

2025 - Springer Healthcare Italia

Fa parte di

Current therapeutics. - Mensile = Monthly
Leggi le condizioni d'uso
Disponibile DownloadDisponibile Copia/IncollaDisponibile Stampa
PDF

Fascicolo
Rivista, Current therapeutics, Springer Healthcare
Fascicolo, Current therapeutics : XXVIII, 3, 2025, Springer Healthcare
Fascicolo, Therapy perspectives : for rational drug use & disease management : XXVI, 4, 2023, Springer Healthcare

Therapy perspectives : for rational drug use & disease management : XXVI, 4, 2023
[Trientine formulations : pharmacological insights for a clinical perspective]

2023 - Springer Healthcare Italia

Fa parte di

Therapy perspectives : for rational drug use & disease management. - Trimestrale = Three-monthly
Leggi le condizioni d'uso
Disponibile DownloadDisponibile Copia/IncollaDisponibile Stampa
PDF

Fascicolo
Rivista, Therapy perspectives : for rational drug use & disease management, Springer Healthcare
Pagina 1 di 1